|
|
|
|
||
Re: More or less honesty needed at LGND?13:03 | LGND | (108.90 -22.87) Ligand Pharma down 18% following Citron report; down 60% since September Citron will expose some of the dirtier secrets of Ligand and will explain why Ligand is a company designed for the “lazy investor” whose stock price has 80% downside from its current levels once people READ. |
return to message board, top of board |